Skip to main content

Ontario Cancer Institute Taps Geospiza for Genetic Analysis Software

NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research will use Geospiza’s genetic analysis software in its sequencing programs for cancer research, the company said today.
 
Under the agreement, Toronto-based OICR will use the company’s FinchLab software in its cancer studies. The not-for-profit institute is funded by the Ontario government under the Ministry of Research and Innovation.
 
In April, OICR said it received CA$60 million ($58.8 million), which it plans to spend on building up its cancer research program, starting new initiatives, and stocking up on new equipment.
 
The FinchLab platform will support analysis projects for data from OICR’s next-generation sequencing instruments, such as the Illumina Genome Analyzer and Applied Biosystems’ SOLiD, the Seattle-based company said.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.